As Veeva and Salesforce go their separate ways, why it's all to play for in the life sciences market

Our CRM business is healthy, and it is an important part of Veeva, but it's not the major -- it's not the largest part of Veeva anymore, that’s for sure.

Disruption is coming to the CRM environment, and doing nothing is not an option. Nearly every pharmaceutical company will have to redeploy their CRM in the next few years as two major players emerge, Veeva Vault CRM and Salesforce Life Sciences Cloud. Whether migrating an existing Veeva solution or forging a new path with Salesforce, this moment represents a much larger opportunity than simply choosing a technology platform. Companies can holistically reexamine the ways in which they want to engage with customers in the future and how their CRM can help them to meet their strategic goals.

Choosing which CRM platform to adopt—and how to implement it—will have a significant impact on the global commercial operations ...